Investigation of pleiotropic effect of DPP-4 inhibitor, sitagliptin for type 2 diabetic patients with old myocardial infarction
Phase of Trial: Phase IV
Latest Information Update: 24 Jan 2018
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary) ; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms MUSIC-FAIR
- 18 Jan 2018 Status changed from active, no longer recruiting to completed.
- 30 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Dec 2013 New trial record